These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 71952)

  • 21. Immunological properties of Fc receptor on lymphocytes. 7. Suppression of mixed lymphocyte reaction by Fc receptor-bearing splenic lymphocytes.
    Kuribayashi K; Takabayashi A; Miyama M; Yamada J; Masuda T
    Cell Immunol; 1979 Sep; 46(2):373-83. PubMed ID: 158435
    [No Abstract]   [Full Text] [Related]  

  • 22. Antigen-specific T cell-mediated suppression. IV. Role of macrophages in generation of L-glutamic acid60-L-alanine30-L-tyrosine10 (GAT)-specific suppressor T cells in responder mouse strains.
    Pierres M; Germain RN
    J Immunol; 1978 Oct; 121(4):1306-14. PubMed ID: 81227
    [No Abstract]   [Full Text] [Related]  

  • 23. The biologic effects of allogeneic factor on T lymphocytes. II. The specificity of AEF-induced cytotoxic T lymphocytes.
    Altman A; Cardenas JM; Bechtold TE; Katz DH
    J Immunol; 1980 Jan; 124(1):114-20. PubMed ID: 6153087
    [No Abstract]   [Full Text] [Related]  

  • 24. Suppression of cytotoxic response to histoincompatible cells. I. Evidence for two types of T lymphocyte-derived suppressors acting at different stages in the induction of a cytotoxic response.
    Gorczynski RM; MacRae S
    J Immunol; 1979 Mar; 122(3):737-46. PubMed ID: 312822
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vitro recognition of alloantigens: nature of responding and stimulating cells.
    Berman M; Puryear K; Argyris BF
    Cell Immunol; 1976 Apr; 23(1):126-39. PubMed ID: 131649
    [No Abstract]   [Full Text] [Related]  

  • 26. Regulation of the immune response T-cell interactions.
    Dutton RW; Swain SL
    CRC Crit Rev Immunol; 1982 Feb; 3(3):209-61. PubMed ID: 6176399
    [No Abstract]   [Full Text] [Related]  

  • 27. Some effects thymocyte-stimulating factor.
    Chen DM; Sabato GD
    Cell Immunol; 1977 May; 30(2):195-203. PubMed ID: 16698
    [No Abstract]   [Full Text] [Related]  

  • 28. Arming of macrophages with lymphocytes from mice immunized with tumor tissue.
    Horowitz M; Argyris BF
    Immunol Commun; 1977; 6(3):297-319. PubMed ID: 69610
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Ly phenotype of suppressor T cells arising in mice subjected to a graft-versus-host reaction.
    Pickel K; Hoffmann MK
    J Exp Med; 1977 May; 145(5):1169-75. PubMed ID: 16073
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cell-mediated cytotoxicity to non-MHC alloantigens on mouse epidermal cells. II. Genetic basis of the response of C3H mice.
    Steinmuller D; Tyler JD; David CS
    J Immunol; 1981 May; 126(5):1754-8. PubMed ID: 7217663
    [No Abstract]   [Full Text] [Related]  

  • 31. Diminished cellular cytotoxicity in mice hyperimmunized prior to skin grafting.
    Sugarbaker PH
    Cell Immunol; 1981 Jan; 57(1):99-113. PubMed ID: 6783318
    [No Abstract]   [Full Text] [Related]  

  • 32. Inhibition of cytotoxic responses by prostaglandin E2 in the presence of interleukin 2.
    Wolf M; Droege W
    Cell Immunol; 1982 Sep; 72(2):286-93. PubMed ID: 6983912
    [No Abstract]   [Full Text] [Related]  

  • 33. Graft versus host-induced immunosuppression: mechanism of depressed T-cell helper function in vitro.
    Elie R; Lapp WS
    Cell Immunol; 1977 Nov; 34(1):38-48. PubMed ID: 21034
    [No Abstract]   [Full Text] [Related]  

  • 34. The differentiation of cytotoxic T cells in vitro. III. The role of helper T cells and their products in the differentiation of cytotoxic cells from "memory" cell populations.
    Okada M; Henney CS
    J Immunol; 1980 Aug; 125(2):850-7. PubMed ID: 6446579
    [No Abstract]   [Full Text] [Related]  

  • 35. Genetic control of the T lymphocyte proliferative response to staphylococcal nuclease: evidence for multiple MHC-linked Ir gene control.
    Schwartz RH; Berzofsky JA; Horton CL; Schechter AN; Sachs DH
    J Immunol; 1978 May; 120(5):1741-9. PubMed ID: 307022
    [No Abstract]   [Full Text] [Related]  

  • 36. The requirement of Ia-positive accessory cells for the induction of tumor-specific cytotoxic T lymphocytes in vitro.
    Yamashita U; Nakamura H
    Cell Immunol; 1981 Aug; 62(2):425-35. PubMed ID: 6169456
    [No Abstract]   [Full Text] [Related]  

  • 37. Diseases caused by reactions of T lymphocytes to incompatible structures of the major histocompatibility complex. III. Autoantibodies to thymocytes.
    van der Veen JP; Rolink AG; Gleichmann E
    J Immunol; 1981 Oct; 127(4):1281-6. PubMed ID: 6974187
    [No Abstract]   [Full Text] [Related]  

  • 38. Modulation of F1 cytotoxic potentials by graft-vs-host reaction. Cooperative non-H-2- and H-2D region-gene control of F1 natural resistance to graft-vs-host reaction-associated immunosuppression.
    Ishikawa H; Saito K; Kubota E
    J Immunol; 1989 Mar; 142(5):1495-9. PubMed ID: 2918225
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Education of human lymphocytes against mouse cells: specific recognition of H-2 antigens.
    Carnaud C; Fadaï-Ghotbi M; Lesavre P; Bach JF
    Eur J Immunol; 1977 Feb; 7(2):81-5. PubMed ID: 68884
    [No Abstract]   [Full Text] [Related]  

  • 40. Specificity of cell-mediated transplantation reactions. II. Studies with a sensitive assay of cell-mediated cytotoxicity.
    Lake P; Sabbadini E; Sehon AH
    Immunology; 1974 Sep; 27(3):441-55. PubMed ID: 4137937
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.